CIPP Rett Centre

 

The CIPP Rett Centre is a clinical treatment and research centre for children and adults with Rett Syndrome and related disorders of all ages.

Based at King’s College Hospital, the Centre monitors children and adults with Rett Syndrome and related disorders nationally through the CIPP Rett Database and conducts clinical trials.

The CIPP Rett Centre accepts referrals from a variety of sources. These include Consultants from various specialities (including paediatricians and neurologists), GPs, patient organisations and self-referrals. To refer a patient to the CIPP Rett Centre, email: cpmrs@slam.nhs.uk or contact rachael@reverserett.org.uk for more info.

CIPP Rett Centre intervention is based on a holistic multi-modal approach. As part of the referral process, parents/carers will be asked to complete a battery of online questionnaires which will inform the acceptance and prioritisation of the referral. Local services are expected to be either involved or be willing to work within a Shared Care Protocol in order to optimise outcomes quickly.

 

CIPP Rett Database

The CIPP Rett Database is an online system through which the CIPP Rett team are able to monitor the well-being of UK patients with Rett Syndrome and related disorders at a distance.

Being part of the CIPP Rett Database is also a way of helping with efforts to bring about treatments for Rett Syndrome.

The more patients who are on the database, the more information the team is able to gather about Rett Syndrome, how it affects UK patients and the need for treatment.

You can add your child or adult with Rett Syndrome to the CIPP Rett Database by emailing: cipp_rett@reverserett.org.uk.

    Contact Details


     

    Any enquiries, please email rachael@reverserett.org.uk

    Latest news

    View: All
    • What is gene therapy and how can it help people with Rett syndrome?

      What is gene therapy and how can it help people with Rett syndrome?

      September 2023   Emerging Gene Therapies Bitesize – Session 1 Reverse Rett CEO Rachael Stevenson
      Read More
    • The UK Rett Syndrome community is at a pivotal moment at the moment with two clinical trials of gene therapies underway. 

      The UK Rett Syndrome community is at a pivotal moment at the moment with two clinical trials of gene therapies underway. 

      Much is going to be required of our very small, rare disease organisation at
      Read More
    • Neurogene doses first paediatric patients in US clinical trial of NGN-401 gene therapy 

      Neurogene doses first paediatric patients in US clinical trial of NGN-401 gene therapy 

      November 30th 2023-Neurogene has announced today that they have dosed the first two female
      Read More